Submit your startup to get matched with investors. Healthcare VC firms differ in the companies they back, so build your shortlist around your stage, product category, and business model rather than relying on a broad healthcare label.
How do healthcare VC firms differ by investment focus?
Healthcare investing includes specialist funds and generalist firms with dedicated healthcare practices. Rock Health, OrbiMed, Flare Capital, and Town Hall Ventures focus on healthcare or related areas. General Catalyst, Bessemer, Lux Capital, and a16z Bio + Health are examples of broader firms with healthcare interests. Their investment mandates and preferred stages are not interchangeable.
Start by describing what your company actually builds. Healthtech investors generally consider software and care-delivery products. Medtech investors focus on physical devices and diagnostics, while biotech investors back drug and platform science, which can involve different timelines. If you describe your company only as “healthcare,” you may leave investors unclear about where it fits.
The product category is just one filter. Your stage and payment model also matter. A software company selling to health systems may need a different investor fit from a consumer-directed health product or a science-led company. Define the buyer, user, and source of payment before you begin ranking firms.
Which healthcare investors may fit your business model?
These examples show areas of focus. They are not guarantees of funding or endorsements. Use them to assess whether an investor’s interests appear relevant to your company.
- Digital health at seed: Rock Health invests in digital health companies at the seed stage, with checks often in the $1M-$3M range, and releases an annual funding report. 7wireVentures backs consumer-led healthcare, engagement, and value-based care models, with a $1M-$3M range.
- AI-enabled clinical software: Define Ventures supports founders developing AI-enabled clinical and care-delivery software from seed to Series A. a16z Bio + Health, Andreessen Horowitz’s dedicated bio and health practice, invests in AI applications across healthcare software and services.
- Healthcare technology: Flare Capital Partners concentrates on healthcare technology companies from seed to Series B. Its health-system-aligned backers offer portfolio companies access to pilots.
- Underserved populations: Town Hall Ventures invests in companies serving underserved populations and care connected to Medicaid and Medicare. Former acting CMS head Andy Slavitt co-founded the firm.
- Deep-tech health: Lux Capital backs medical devices and AI diagnostics, including opportunities involving hardware and frontier science.
- Broader or later-stage mandates: OrbiMed invests across biotech and healthtech. Oak HC/FT focuses on the billing, payments, and insurance infrastructure around care at the growth stage. General Catalyst works on health-system transformation and acquired Summa Health through its HATCo vehicle.
- Science-led company creation: ARCH Venture Partners looks for science-intensive, biotech-adjacent opportunities and may create companies around research rather than invest in a pitch deck.
- Broad health interests: StartUp Health invests across a broad portfolio and combines funding with community and coaching.
Digital health seed checks often fall in the $1M-$3M range, but regulatory and clinical diligence can extend the time needed to close a round. If you are raising at seed, first assess whether a firm’s mandate matches your company. Then consider whether you have a relevant warm path. An introduction from a portfolio founder or a shared health-system advisor may be more useful than contacting every firm cold at once.
What should you prepare before speaking with healthtech investors?
Investors need to understand what must happen between a product and revenue. Be ready to explain your regulatory pathway and how the product will be paid for. These are practical parts of the business model, not details to leave until after your first conversations.
For regulation, explain whether the product is FDA Class I, II, or III, whether clearance is needed, or whether the product is wellness-oriented. For reimbursement, clarify whether a CPT code exists or whether you sell directly to health systems, payers, or consumers. Make the answer to “How does this get paid for?” specific to your company.
Clinical validation and distribution also matter. Be prepared to describe evidence such as a named health-system pilot, a published outcome, or a peer-reviewed result. Explain how the product reaches its users or buyers, as well as what it does. A concise account of these points can help you present the company’s path to adoption and revenue clearly.
How can you build a focused healthcare investor shortlist?
First, narrow the field by stage and product subcategory. Then compare each potential investor’s mandate with your business model. A firm’s use of the word “healthcare” alone does not establish that it is a fit for your company.
Once you have a relevant group, order it by mandate overlap and warm-path proximity. This helps you avoid treating every firm as an equally suitable prospect or sending the same message to every name at once.
Keep the first email under 150 words. Include what you built, who pays, one real traction or pilot data point, and a low-friction ask. For healthtech, make the payment model and clinical relevance easy to assess. Follow up twice, then move on after three touches without a reply.
Round Funded covers 60,000+ active VCs, angels, family offices, and accelerators. Founders can search by stage, industry, geography, and check size. Investors are filtered to recent activity, roughly a check in the last six months, and emails are verified. Explore investor matching through Round Funded to submit your startup and get matched with investors.
How Round Funded helps founders build an investor shortlist
- Submit your startup on Round Funded to get matched with investors.
- Explore investor options for your company by searching investors by stage, industry, geography, and check size.
- Use AI to draft personalized outreach emails and follow-ups for each investor.
- Send outreach from your own Gmail, so replies land in your inbox and the email thread belongs to you.
- Track investors, fundraising stages, and next steps in the CRM pipeline. You can also build and share a Data Room with your deck, traction, team, and ask on one link. It is free to build and share on every plan.
Frequently Asked Questions
Which healthcare VC firms invest in digital health at seed?
Rock Health invests in digital health companies at seed, with checks often in the $1M-$3M range. 7wireVentures backs consumer-led healthcare, engagement, and value-based care models, with a $1M-$3M range.
How do healthtech, medtech, and biotech investors differ?
Healthtech investors focus on software and care-delivery products. Medtech investors focus on physical devices and diagnostics. Biotech investors focus on drug and platform science, which can involve different timelines.
What do healthcare investors want to know about a startup?
Be ready to explain your regulatory pathway, reimbursement or payment model, clinical validation, and distribution. Investors may want to understand whether clearance is needed, who pays, and what evidence supports the product.
How should you prioritize healthcare investors?
Start with investors whose stage and mandate match your company. Then consider warm-path proximity. A focused list can help you tailor your outreach rather than sending the same message to every firm.
Why might a healthtech seed round take longer to close?
Digital health seed rounds may take longer because of regulatory and clinical diligence. Clear answers about the regulatory pathway, reimbursement, and clinical validation help explain the steps between product and revenue.